KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) is a Medical instruments supplies company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for KESTRA MEDICAL TECHNOLOGIES, LTD. in 2026. The next earnings report is expected on September 10, 2026.
Next earnings date
10 Sep 2026
In 20 days
EPS estimate
-0.62
Revenue estimate
29.0M
Past earnings
No dividend history available.
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) is scheduled to report earnings on September 10, 2026.
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) last reported earnings on July 14, 2026.
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.